First-Time Founder
Graduate Student Founder
Female FounderActively RaisingAbout
AI-programmable DNA regulatory switches enabling tumor-selective gene therapy activation. A control layer platform for cell and gene therapy programs that delivers life-saving therapies to patients faster, cheaper, and more precisely.
Products
OncoSwitch Tumor-Selective Regulatory Platform
AI-powered platform for designing programmable tumor-selective DNA regulatory switches (50–200 bp) for cell and gene therapies. Combines closed-loop AI and MPRA-based functional screening to engineer regulatory elements that preferentially activate therapeutic payloads in target cancer cells while minimizing off-target expression in healthy tissues. Designed to accelerate regulatory sequence discovery and optimization compared to conventional experimental workflows. Compatible with AAV, lentiviral, CAR-T, and other gene therapy platforms.
Click to read more